• Aztreonam in Reliable Cell Assays

  2026-09-21

  This scenario-driven guide explains how Aztreonam, SKU A5931, can be incorporated into cell viability, proliferation, cytotoxicity, and Gram-negative research workflows. It covers mechanism, cell-model compatibility, stock preparation, resistance interpretation, and practical supplier-selection criteria using product data and recent resistance literature.

• Microfluidic Peptide/RNA Complexes for Pulmonary Delivery

  2026-09-21

  This 2025 study examined whether microfluidic mixing could produce reproducible peptide–RNA complexes that remain suitable for pulmonary nebulisation. Both LAH4-L1 and PEG12KL4 preserved RNA binding and in vitro transfection performance after vibrating-mesh nebulisation, supporting their further evaluation as non-viral pulmonary delivery systems.

• Meropenem trihydrate in Resistance Research

  2026-09-20

  Use Meropenem trihydrate to connect growth inhibition, resistance phenotyping, and metabolomics in reproducible bacterial workflows. This guide translates recent LC-MS/MS findings into practical assay design, optimization, and troubleshooting strategies for antibiotic resistance studies.

• Isoproterenol sulfate dihydrate for SAN Assays

  2026-09-19

  Use Isoproterenol sulfate dihydrate as a controlled beta-adrenergic challenge to distinguish intrinsic pacemaker maturation from acute neuro-cardiac modulation in human SAN assembloids. This workflow combines dose-controlled physiology, cAMP/PKA pathway readouts, and compartment-specific controls for more interpretable cardiovascular research.

• ARCA Cy5 EGFP mRNA (5-moUTP) for Assays

  2026-09-18

  Learn how ARCA Cy5 EGFP mRNA (5-moUTP), SKU R1009, can separate delivery, localization, and translation variables in mammalian-cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers assay compatibility, handling, interpretation, and practical product-selection criteria.

• CHIR-99021 Workflows for Wnt and Stem Cells

  2026-09-18

  CHIR-99021 (CT99021) provides selective, cell-permeable GSK-3α/β inhibition for controlling pluripotency, lineage commitment, and Wnt-responsive degradation assays. This guide translates its molecular profile into practical stem-cell workflows, with special attention to pulse timing, solvent handling, reporter design, and troubleshooting pathway-specific effects.

• Triacetin Workflows for Cell and Metabolic Research

  2026-09-17

  Triacetin, or glyceryl triacetate, supports distinct glioblastoma, metabolic, ocular-formulation, and lipid-focused workflows. This practical guide separates reported biological activity from formulation utility, with concentration selection, controls, and troubleshooting steps for reproducible assays.

• Cepharanthine in Endometriosis: Organoid & In Vivo

  2026-09-17

  A 2026 study evaluates the biscoclaurine alkaloid Cepharanthine across immortalized stromal cells, patient-derived endometrial organoids, and a murine peritoneal endometriosis model. Its findings connect lesion-growth suppression with G0/G1 arrest, DNA damage, impaired repair, and mitochondrial apoptosis, while also illustrating how organoids can improve preclinical treatment evaluation.

• CBD, FAAH, and Orofacial Inflammatory Pain

  2026-09-16

  This 2026 mouse study shows that cannabidiol (CBD) can reduce both inflammatory orofacial nociception and pain-associated affective and cognitive deficits. By combining behavioral, biochemical, endocannabinoid, and circuit-level analyses, the work links peripheral CB2-associated signaling, central CB1-associated anandamide regulation, and altered serotonin dynamics in the central amygdala.

• Iptacopan Monotherapy in PNH: Evidence and Methods

  2026-09-16

  This phase 2 proof-of-concept study evaluated oral Iptacopan (LNP023) as single-agent factor B inhibition in treatment-naive patients with active paroxysmal nocturnal hemoglobinuria. Rapid reductions in LDH and other hemolytic markers, together with improved hemoglobin and reduced transfusion requirements, support proximal alternative-pathway inhibition as a clinically relevant strategy, while the small open-label design limits generalization.

• Capsaicin: From TRPV1 Signaling to KDM1A

  2026-09-15

  Capsaicin is more than a canonical sensory-neuron agonist. Its rapid TRPV1 ion channel activation and reversible KDM1A/LSD1 inhibition create a translational framework linking pain, inflammation, itch, and gastric cancer research—provided that investigators separate exposure, target engagement, and phenotype.

• HyperScript™ Reverse Transcriptase for RPE RNA

  2026-09-15

  Learn how HyperScript™ Reverse Transcriptase can support RNA to cDNA conversion when RPE/choroid samples contain low-abundance transcripts or structured RNA. This workflow-focused guide connects microbiome-associated retinal transcriptomics with practical qPCR validation, control design, and troubleshooting.

• Dynasore: Dynamin GTPase Inhibitor Guide

  2026-09-14

  Dynasore is a reversible, cell-permeable dynamin GTPase inhibitor used to dissect dynamin-dependent endocytosis and membrane trafficking. Its approximately 15 µM biochemical IC50 is a benchmark rather than a universal cellular dose, so assay-specific controls and orthogonal validation are essential.

• ARCA Cy5 EGFP mRNA in Macrophage Assays

  2026-09-14

  ARCA Cy5 EGFP mRNA (5-moUTP) enables researchers to distinguish macrophage uptake from productive translation in mRNA delivery studies. This article develops an assay framework for connecting nanoparticle design, intracellular trafficking, and expression outcomes.

• D-N-Acetylgalactosamine: Protocol and QC Guide

  2026-09-13

  D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for glycoprotein composition studies, brain heteropolysaccharides analysis, and related glycosylation pathway workflows. It is appropriate for aqueous or validated DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.

8047 records 1/537 page Next 12345 下5页 Last page